profits indian drugmaker dr reddys fell 93 research costs rose sales flagged
firm said profits 40m rupees 915000 Â£486000 three months december sales fell 8 47bn rupees
dr reddys built reputation producing generic versions bigname pharmaceutical products
competition intensified firm company short new product launches
recent annoucement december 2000 exclusive marketing rights generic version famous antidepressant prozac maker eli lilly
lost key court case march 2004 banning selling version pfizers popular hypertension norvasc us
research development new drugs continuing apace rd spending rising 37 705m rupees key cause decrease profits alongside fall sales
patents number wellknown products due run near future representing opportunity dr reddy whose shares listed new york indian generics manufacturers
sales dr reddys generics business fell 86 966m rupees
another staple firms business ingredients drugs performed poorly
sales 25 previous year 14bn rupees strong competition home us europe
dr reddys indian competitors gathering strength although heavy competitive pressures

